SCHEMBL29299105

SCHEMBL29299105

c1ccc(-c2ccc(N(c3ccccc3)c3ccc(-c4cccc5c4oc4cccc(-c6nc7ccccc7s6)c45)cc3)cc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 3/20 0.43
▸ MAPT P10636 6/20 0.38
▸ ALDH1A1 P00352 6/20 0.38
▸ RAB9A P51151 5/20 0.38
▸ KDM4E B2RXH2 4/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ NPC1 O15118 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ GAA P10253 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ POLB P06746 3/20 0.37
▸ HPGD P15428 2/20 0.37
▸ THRB P10828 1/20 0.37
▸ CTDSP1 Q9GZU7 1/20 0.37
▸ NFKB1 P19838 2/20 0.36
▸ NFKB2 Q00653 2/20 0.36
▸ RELA Q04206 2/20 0.36
▸ LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25543630 0.89 APP (0.47) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL25543158 0.88 APP (0.48) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL23328456 0.85 APP (0.50) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL29298444 0.84 APP (0.46) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL22177819 0.82 APP (0.44) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL22177960 0.82 RAB9A (0.40) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL22178050 0.82 RAB9A (0.40) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL29299101 0.82 APP (0.41) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL25543830 0.82 RAB9A (0.51) APPMAPTALDH1A1RAB9AKDM4E
SCHEMBL22592925 0.82 RAB9A (0.42) APPMAPTALDH1A1RAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 — — US disclosed
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER LT MATERIALS CO., LTD. (KR) 2024-07-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240237514-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME AND COMPOSITION FOR ORGANIC MATERIAL LAYER CYP1A1, CYP1B1, CYP2E1 APP 326/4885MAPT 1117/4885ALDH1A1 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback